Get 20% lifetime commission for referring investors to digrin.com
here.
Mayne Pharma Group Limited ( MAYNF) - Key Metrics
MAYNF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $2.11 | $0.48 | $0.29 | $0.27 |
| 2026Q2 | $2.61 | -$0.18 | -$0.10 | -$0.12 |
| 2025Q4 | $2.53 | -$0.89 | $0.40 | $0.33 |
| 2025Q2 | $2.69 | -$0.32 | -$0.16 | -$0.25 |
| 2024Q4 | $2.54 | -$1.31 | $0.17 | $0.11 |
MAYNF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | 1.22 |
| 2026Q2 | 0% | -4.31 |
| 2025Q4 | 0% | -1.42 |
| 2025Q2 | 0% | -4.51 |
| 2024Q4 | 0% | -0.91 |
MAYNF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 11.37% | 0% |
| 2026Q2 | -3.72% | 0% |
| 2025Q4 | 6.44% | 0% |
| 2025Q2 | -5.58% | 0% |
| 2024Q4 | 2.43% | 0% |
MAYNF
Price: $1.85
52 week price:
Earnings Per Share: 0.28 USD
P/E Ratio: 8.39
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 166.6 million